Clinical trial
Sublingual Immunotherapy With House Dust Mite Extract in Asthmatic Children
NCT00172341 · National Taiwan University Hospital, Other · Unknown status
Key facts
| NCT number | NCT00172341 |
|---|---|
| Title | Sublingual Immunotherapy With House Dust Mite Extract in Asthmatic Children |
| Official title | Efficacy and Safety of Sublingual Immunotherapy With House Dust Mite Extract in Asthmatic Children: A Double-Blind, Randomized, and Placebo-Controlled Study |
| Lead sponsor | National Taiwan University Hospital, Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | Staloral TM |
| Enrollment | 100 |
| First posted | Sep 15, 2005 |
| Last update posted | Nov 3, 2005 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: